A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

November 11, 2008

HIV Can’t Hide From Specially Engineered CD8 Cells

Specially engineered “killer” CD8 cells, modified to more easily recognize and bind to HIV-infected cells, were more effective in the laboratory at controlling HIV reproduction than CD8 cells typically found in the human body, according to a press release detailing a new online report published November 9 by Nature Medicine.

CD4 cells—HIV’s primary target in the human body—have the ability to alert other immune system cells, including CD8s, when they have become infected with the virus. CD4s do this by displaying small chunks of viral proteins on their surfaces. When the receptors on CD8 cells come into contact with these viral proteins, they recognize them as foreign to the body and act to kill the infected cell. Unfortunately, HIV is able to evade this defense because it mutates so rapidly.

James Riley, PhD, from the University of Pennsylvania, and his colleagues in Philadelphia and at Cardiff University in Wales were able to isolate a group of CD8-cell genes that make receptors that are 450 times more sensitive to HIV-infected cells than normal CD8 cell receptors. Riley’s team genetically engineered a population of CD8 cells to produce these more powerful receptors and then placed them in a cell culture along with HIV.

“Not only could [CD8] cells be engineered to express the strongly binding [CD8]-cell receptor to see HIV strains that had escaped detection by natural [CD8] cells,” Riley said, “but the engineered [CD8] cells responded in a much more vigorous fashion so that far fewer [CD8] cells were required to control infection.”

Riley and his colleagues hope to begin clinical trials next year in HIV-positive patients who are heavily treatment experienced, potentially followed by trials in people recently infected with HIV. The primary aim of the early trials will be to ensure the safety of the engineered CD8 cells and to determine how many a person may need to control HIV reproduction.

Search: CD4, CD8, engineered, cell receptor, James Riley, University of Pennsylvania, Cardiff University


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Keith Kvochick, Houston, 2008-11-20 17:17:27
So how would I keep track of Rileys research, and when he might be ready for volunteers. I have been HIV+ for over 20 years and on drug therapy for over 17 years. I would gladly be in his first round of tests.

Davis, Nairobi, 2008-11-13 10:17:06
I am encouraged by the research even though many others have been reported in the past which have given hope to many of us that soon, just may be soon, a breaktrhough may come. I guess this research means the genetically engineered cd8 cells would control production of the virus and by natural process, eliminate it completely in the body.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    bigmama41
    greensboro
    North Carolina


    PhilipBnFL
    Dallas
    Texas


    jonjonhg
    nyc
    New York


    jonhart48
    Stamford
    Connecticut
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.